GENENTA SCIENCE SPA - ADR (GNTA) Fundamental Analysis & Valuation

NASDAQ:GNTA • US36870W1009

Current stock price

0.6926 USD
+0.02 (+2.58%)
At close:
0.6546 USD
-0.04 (-5.49%)
After Hours:

This GNTA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. GNTA Profitability Analysis

1.1 Basic Checks

  • In the past year GNTA has reported negative net income.
  • GNTA had a negative operating cash flow in the past year.
  • In the past 5 years GNTA always reported negative net income.
  • In the past 5 years GNTA always reported negative operating cash flow.
GNTA Yearly Net Income VS EBIT VS OCF VS FCFGNTA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • The Return On Assets of GNTA (-40.37%) is comparable to the rest of the industry.
  • GNTA has a Return On Equity of -71.82%. This is comparable to the rest of the industry: GNTA outperforms 52.61% of its industry peers.
Industry RankSector Rank
ROA -40.37%
ROE -71.82%
ROIC N/A
ROA(3y)-45.86%
ROA(5y)-36.67%
ROE(3y)-51.85%
ROE(5y)-41.34%
ROIC(3y)N/A
ROIC(5y)N/A
GNTA Yearly ROA, ROE, ROICGNTA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 -20 -40 -60

1.3 Margins

  • GNTA does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
GNTA Yearly Profit, Operating, Gross MarginsGNTA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. GNTA Health Analysis

2.1 Basic Checks

  • GNTA has more shares outstanding than it did 1 year ago.
  • The number of shares outstanding for GNTA has been increased compared to 5 years ago.
  • GNTA has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
GNTA Yearly Shares OutstandingGNTA Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M
GNTA Yearly Total Debt VS Total AssetsGNTA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • GNTA has an Altman-Z score of -3.26. This is a bad value and indicates that GNTA is not financially healthy and even has some risk of bankruptcy.
  • GNTA has a Altman-Z score (-3.26) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.62 indicates that GNTA is somewhat dependend on debt financing.
  • GNTA has a worse Debt to Equity ratio (0.62) than 71.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Altman-Z -3.26
ROIC/WACCN/A
WACCN/A
GNTA Yearly LT Debt VS Equity VS FCFGNTA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M

2.3 Liquidity

  • GNTA has a Current Ratio of 13.20. This indicates that GNTA is financially healthy and has no problem in meeting its short term obligations.
  • GNTA's Current ratio of 13.20 is amongst the best of the industry. GNTA outperforms 88.01% of its industry peers.
  • A Quick Ratio of 13.20 indicates that GNTA has no problem at all paying its short term obligations.
  • With an excellent Quick ratio value of 13.20, GNTA belongs to the best of the industry, outperforming 88.01% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 13.2
Quick Ratio 13.2
GNTA Yearly Current Assets VS Current LiabilitesGNTA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. GNTA Growth Analysis

3.1 Past

  • GNTA shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.88%.
EPS 1Y (TTM)3.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • GNTA is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 5.81% yearly.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y20%
EPS Next 2Y13.68%
EPS Next 3Y5.81%
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
GNTA Yearly EPS VS EstimatesGNTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 -0.2 -0.4 -0.6

More info and screens

Find the best growth stocksShow best growing peers

0

4. GNTA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for GNTA. In the last year negative earnings were reported.
  • Also next year GNTA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
GNTA Price Earnings VS Forward Price EarningsGNTA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
GNTA Per share dataGNTA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.68%
EPS Next 3Y5.81%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. GNTA Dividend Analysis

5.1 Amount

  • No dividends for GNTA!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

GNTA Fundamentals: All Metrics, Ratios and Statistics

GENENTA SCIENCE SPA - ADR

NASDAQ:GNTA (4/7/2026, 4:44:01 PM)

After market: 0.6546 -0.04 (-5.49%)

0.6926

+0.02 (+2.58%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)N/A
Earnings (Next)N/A
Inst Owners17.74%
Inst Owner Change0%
Ins Owners26.3%
Ins Owner Change0%
Market Cap16.23M
Revenue(TTM)N/A
Net Income(TTM)-8.70M
Analysts82.86
Price Target7.14 (930.9%)
Short Float %0.28%
Short Ratio0.03
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-66.67%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)29.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 1.16
P/tB 1.16
EV/EBITDA N/A
EPS(TTM)-0.43
EYN/A
EPS(NY)-0.54
Fwd EYN/A
FCF(TTM)-0.48
FCFYN/A
OCF(TTM)-0.48
OCFYN/A
SpS0
BVpS0.6
TBVpS0.6
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40.37%
ROE -71.82%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-45.86%
ROA(5y)-36.67%
ROE(3y)-51.85%
ROE(5y)-41.34%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.62
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 28.1%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 13.2
Quick Ratio 13.2
Altman-Z -3.26
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)114.19%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)3.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%7.82%
EPS Next Y20%
EPS Next 2Y13.68%
EPS Next 3Y5.81%
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y8.7%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-141.01%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y22.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y22%
OCF growth 3YN/A
OCF growth 5YN/A

GENENTA SCIENCE SPA - ADR / GNTA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for GENENTA SCIENCE SPA - ADR?

ChartMill assigns a fundamental rating of 1 / 10 to GNTA.


Can you provide the valuation status for GENENTA SCIENCE SPA - ADR?

ChartMill assigns a valuation rating of 0 / 10 to GENENTA SCIENCE SPA - ADR (GNTA). This can be considered as Overvalued.


What is the profitability of GNTA stock?

GENENTA SCIENCE SPA - ADR (GNTA) has a profitability rating of 1 / 10.